BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 19731638)

  • 1. KIR genes and their role in spondyloarthropathies.
    Díaz-Peña R; Blanco-Gelaz MA; López-Larrea C
    Adv Exp Med Biol; 2009; 649():286-99. PubMed ID: 19731638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Killer Cell Immunoglobulin-like Receptor Genes and Their HLA Ligands in Iranian Patients with Ankylosing Spondylitis.
    Mahmoudi M; Jamshidi AR; Karami J; Mohseni A; Amirzargar AA; Farhadi E; Ahmadzadeh N; Nicknam MH
    Iran J Allergy Asthma Immunol; 2016 Feb; 15(1):27-38. PubMed ID: 26996109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Killer cell immunoglobulin-like receptors in HLA-B27-associated acute anterior uveitis, with and without axial spondyloarthropathy.
    Levinson RD; Martin TM; Luo L; Ashouri E; Rosenbaum JT; Smith JR; Austin CR; Lutt JR; Rajalingam R
    Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1505-10. PubMed ID: 19850842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activating killer immunoglobulin-like receptors genes are associated with increased susceptibility to ankylosing spondylitis.
    Díaz-Peña R; Vidal-Castiñeira JR; Mulero J; Sánchez A; Queiro R; López-Larrea C
    Clin Exp Immunol; 2015 May; 180(2):201-6. PubMed ID: 25491925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation-Induced Killer Cell Immunoglobulin-like Receptor 3DL2 Binding to HLA-B27 Licenses Pathogenic T Cell Differentiation in Spondyloarthritis.
    Ridley A; Hatano H; Wong-Baeza I; Shaw J; Matthews KK; Al-Mossawi H; Ladell K; Price DA; Bowness P; Kollnberger S
    Arthritis Rheumatol; 2016 Apr; 68(4):901-14. PubMed ID: 26841353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of KIR gene and HLA-C alleles: possible association with susceptibility to HLA-B27-positive patients with ankylosing spondylitis.
    Jiao YL; Zhang BC; You L; Li JF; Zhang J; Ma CY; Cui B; Wang LC; Chen ZJ; Zhao YR
    J Clin Immunol; 2010 Nov; 30(6):840-4. PubMed ID: 20652381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Killer-cell immunoglobulin-like receptors (KIR) and HLA-class I heavy chains in ankylosing spondylitis.
    Cauli A; Piga M; Dessole G; Porru G; Floris A; Vacca A; Desogus E; La Nasa G; Mathieu A
    Drug Dev Res; 2014 Nov; 75 Suppl 1():S15-9. PubMed ID: 25381967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High variability of HLA-B27 alleles in ankylosing spondylitis and related spondyloarthropathies in the population of northern Spain.
    Gonzalez S; Garcia-Fernandez S; Martinez-Borra J; Blanco-Gelaz MA; Rodrigo L; Sanchez del Río J; López-Vazquez A; Torre-Alonso JC; López-Larrea C
    Hum Immunol; 2002 Aug; 63(8):673-6. PubMed ID: 12121675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Killer immunoglobulin receptor genes in spondyloarthritis.
    Kuijpers TW; Vendelbosch S; Berg Mv; Baeten DL
    Curr Opin Rheumatol; 2016 Jul; 28(4):368-75. PubMed ID: 27166924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epistatic interactions between killer immunoglobulin-like receptors and human leukocyte antigen ligands are associated with ankylosing spondylitis.
    Hanson AL; ; Vukcevic D; Leslie S; Harris J; Lê Cao KA; Kenna TJ; Brown MA
    PLoS Genet; 2020 Aug; 16(8):e1008906. PubMed ID: 32804949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.
    Tajik N; Shahsavar F; Nasiri M; Radjabzadeh MF
    Int J Immunogenet; 2010 Jun; 37(3):159-68. PubMed ID: 20193031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognition of classical and heavy chain forms of HLA-B27 by leukocyte receptors.
    Allen RL; Trowsdale J
    Curr Mol Med; 2004 Feb; 4(1):59-65. PubMed ID: 15011960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Yin and Yang of HLA and KIR in human disease.
    Kulkarni S; Martin MP; Carrington M
    Semin Immunol; 2008 Dec; 20(6):343-52. PubMed ID: 18635379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KIR2DS3 is associated with protection against acute myeloid leukemia.
    Shahsavar F; Tajik N; Entezami KZ; Fallah Radjabzadeh M; Asadifar B; Alimoghaddam K; Ostadali Dahaghi M; Jalali A; Ghashghaie A; Ghavamzadeh A
    Iran J Immunol; 2010 Mar; 7(1):8-17. PubMed ID: 20371915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NK cell killer Ig-like receptor repertoire acquisition and maturation are strongly modulated by HLA class I molecules.
    Sleiman M; Brons NH; Kaoma T; Dogu F; Villa-Forte A; Lenoble P; Hentges F; Kotsch K; Gadola SD; Vilches C; Zimmer J
    J Immunol; 2014 Mar; 192(6):2602-10. PubMed ID: 24554773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KIR-like activating natural killer cell receptors and their association with complicated malaria in north India.
    Prakash S; Ranjan P; Ghoshal U; Agrawal S
    Acta Trop; 2018 Feb; 178():55-60. PubMed ID: 29111138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Progress in research on genetic polymorphisms and sequence-based typing of KIR genes].
    Zhen J; Yu Q
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Dec; 33(6):867-870. PubMed ID: 27984624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility to pulmonary tuberculosis in Iranian individuals is not affected by compound KIR/HLA genotype.
    Tajik N; Shah-hosseini A; Mohammadi A; Jafari M; Nasiri M; Radjabzadeh MF; Farnia P; Jalali A
    Tissue Antigens; 2012 Feb; 79(2):90-6. PubMed ID: 22128749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-conventional forms of HLA-B27 are expressed in spondyloarthritis joints and gut tissue.
    Rysnik O; McHugh K; van Duivenvoorde L; van Tok M; Guggino G; Taurog J; Kollnberger S; Ciccia F; Baeten D; Bowness P
    J Autoimmun; 2016 Jun; 70():12-21. PubMed ID: 27036372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
    Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.